MX2022011530A - Cocristales de acido (1r,3s)-3-(5-ciano-4-fenil-1,3-tiazol-2-ilcar bamoil) ciclopentano carboxilico. - Google Patents
Cocristales de acido (1r,3s)-3-(5-ciano-4-fenil-1,3-tiazol-2-ilcar bamoil) ciclopentano carboxilico.Info
- Publication number
- MX2022011530A MX2022011530A MX2022011530A MX2022011530A MX2022011530A MX 2022011530 A MX2022011530 A MX 2022011530A MX 2022011530 A MX2022011530 A MX 2022011530A MX 2022011530 A MX2022011530 A MX 2022011530A MX 2022011530 A MX2022011530 A MX 2022011530A
- Authority
- MX
- Mexico
- Prior art keywords
- cocrystals
- thiazol
- cyano
- phenyl
- carboxylic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/02—Salts; Complexes; Addition compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
- C07C65/03—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring
- C07C65/05—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring o-Hydroxy carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20382194.7A EP3882240A1 (en) | 2020-03-16 | 2020-03-16 | Cocrystals of (1r,3s)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcabamoyl)cyclopentane carboxylic acid |
| PCT/EP2021/056506 WO2021185748A1 (en) | 2020-03-16 | 2021-03-15 | Cocrystals of (1r,3s)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcabamoyl)cyclopentane carboxylic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022011530A true MX2022011530A (es) | 2022-10-13 |
Family
ID=69953938
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022011530A MX2022011530A (es) | 2020-03-16 | 2021-03-15 | Cocristales de acido (1r,3s)-3-(5-ciano-4-fenil-1,3-tiazol-2-ilcar bamoil) ciclopentano carboxilico. |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US12384754B2 (enExample) |
| EP (2) | EP3882240A1 (enExample) |
| JP (1) | JP7779846B2 (enExample) |
| KR (1) | KR20220154791A (enExample) |
| CN (1) | CN115298169B (enExample) |
| AU (1) | AU2021237686B2 (enExample) |
| BR (1) | BR112022018449A2 (enExample) |
| CA (1) | CA3171894C (enExample) |
| DK (1) | DK4121419T3 (enExample) |
| ES (1) | ES3002084T3 (enExample) |
| FI (1) | FI4121419T3 (enExample) |
| HR (1) | HRP20241515T1 (enExample) |
| HU (1) | HUE068886T2 (enExample) |
| LT (1) | LT4121419T (enExample) |
| MX (1) | MX2022011530A (enExample) |
| PL (1) | PL4121419T3 (enExample) |
| PT (1) | PT4121419T (enExample) |
| RS (1) | RS66214B1 (enExample) |
| SI (1) | SI4121419T1 (enExample) |
| WO (1) | WO2021185748A1 (enExample) |
| ZA (1) | ZA202211247B (enExample) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2331220B1 (es) * | 2007-10-02 | 2010-09-23 | Palobiofarma, S.L. | Nuevos compuestos como antagonistas de los receptores a1 de adenosina. |
| US8779146B2 (en) | 2010-04-28 | 2014-07-15 | Nuformix Limited | Cilostazol cocrystals and compositions |
| HRP20211104T1 (hr) | 2017-03-06 | 2021-10-15 | Palobiofarma, S.L. | Aminska sol (1r,3s)-3-(5-cijano-4-fenil-1,3-tiazol-2-ilkarbamoil)ciklopentankarboksilne kiseline |
-
2020
- 2020-03-16 EP EP20382194.7A patent/EP3882240A1/en not_active Withdrawn
-
2021
- 2021-03-15 AU AU2021237686A patent/AU2021237686B2/en active Active
- 2021-03-15 DK DK21710531.1T patent/DK4121419T3/da active
- 2021-03-15 PT PT217105311T patent/PT4121419T/pt unknown
- 2021-03-15 JP JP2022555805A patent/JP7779846B2/ja active Active
- 2021-03-15 CA CA3171894A patent/CA3171894C/en active Active
- 2021-03-15 ES ES21710531T patent/ES3002084T3/es active Active
- 2021-03-15 SI SI202130224T patent/SI4121419T1/sl unknown
- 2021-03-15 MX MX2022011530A patent/MX2022011530A/es unknown
- 2021-03-15 PL PL21710531.1T patent/PL4121419T3/pl unknown
- 2021-03-15 CN CN202180021708.3A patent/CN115298169B/zh active Active
- 2021-03-15 RS RS20241203A patent/RS66214B1/sr unknown
- 2021-03-15 FI FIEP21710531.1T patent/FI4121419T3/fi active
- 2021-03-15 US US17/906,367 patent/US12384754B2/en active Active
- 2021-03-15 HR HRP20241515TT patent/HRP20241515T1/hr unknown
- 2021-03-15 WO PCT/EP2021/056506 patent/WO2021185748A1/en not_active Ceased
- 2021-03-15 KR KR1020227035871A patent/KR20220154791A/ko active Pending
- 2021-03-15 BR BR112022018449A patent/BR112022018449A2/pt unknown
- 2021-03-15 EP EP21710531.1A patent/EP4121419B1/en active Active
- 2021-03-15 LT LTEPPCT/EP2021/056506T patent/LT4121419T/lt unknown
- 2021-03-15 HU HUE21710531A patent/HUE068886T2/hu unknown
-
2022
- 2022-10-13 ZA ZA2022/11247A patent/ZA202211247B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021185748A1 (en) | 2021-09-23 |
| PL4121419T3 (pl) | 2025-02-17 |
| CN115298169B (zh) | 2024-11-19 |
| EP4121419B1 (en) | 2024-08-14 |
| PT4121419T (pt) | 2024-11-18 |
| ZA202211247B (en) | 2023-12-20 |
| US12384754B2 (en) | 2025-08-12 |
| AU2021237686A1 (en) | 2022-10-06 |
| BR112022018449A2 (pt) | 2022-11-01 |
| SI4121419T1 (sl) | 2025-02-28 |
| JP2023517722A (ja) | 2023-04-26 |
| HRP20241515T1 (hr) | 2025-01-03 |
| HUE068886T2 (hu) | 2025-02-28 |
| CA3171894C (en) | 2025-03-11 |
| RS66214B1 (sr) | 2024-12-31 |
| JP7779846B2 (ja) | 2025-12-03 |
| CA3171894A1 (en) | 2021-09-23 |
| FI4121419T3 (fi) | 2024-11-04 |
| DK4121419T3 (da) | 2024-10-28 |
| KR20220154791A (ko) | 2022-11-22 |
| AU2021237686B2 (en) | 2026-04-09 |
| US20230183195A1 (en) | 2023-06-15 |
| LT4121419T (lt) | 2024-11-25 |
| EP3882240A1 (en) | 2021-09-22 |
| EP4121419A1 (en) | 2023-01-25 |
| ES3002084T3 (en) | 2025-03-06 |
| CN115298169A (zh) | 2022-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR20240003A (es) | Restos de administración terapéutica novedosos y usos de estos | |
| ZA202403388B (en) | Small molecules for treatement of cancer | |
| MX2021000925A (es) | Inhibidores de inflamasoma nlrp3. | |
| PH12021551635A1 (en) | Hexone glucokinase inhibitor and use thereof | |
| MX2023003627A (es) | Derivados de 1,2,3,4-tetrahidroquinolina como inhibidores de la activacion de yap/taz-tead para el tratamiento del cancer. | |
| WO2016070151A8 (en) | Methods and compositions relating to microbial treatment and diagnosis of disorders | |
| WO2016200101A3 (ko) | 트리사이클릭 유도체 화합물, 이의 제조방법 및 이를 포함하는 약학적 조성물 | |
| PH12022553019A1 (en) | Il-17a modulators | |
| EP4252755A3 (en) | Therapeutic compounds | |
| TW200736213A (en) | Dicarboxylic acid derivatives and their use | |
| WO2022268935A3 (en) | Process for the preparation of nlrp3 inhibitors | |
| EP4364805A3 (en) | Novel pyridazines | |
| NO20074318L (no) | Anvendelse av en fettsyresammensetning som inneholder DHA for fremstilling av et medisinsk produkt eller et naeringsmiddel for behandling av amyloidoserelaterte sykdommer | |
| PH12022552773A1 (en) | Tetrahydroisoquinoline compounds as nrf2 activators | |
| NZ762437A (en) | Novel heterocyclic compounds as cdk8/19 inhibitors | |
| CA3242612A1 (en) | Deuterium-enriched piperidinyl-methyl-purine amines and related compounds and their use in treating diseases and conditions | |
| WO2022192594A3 (en) | Nucleic acid molecules and vaccines comprising same for the prevention and treatment of coronavirus infections and disease | |
| WO2021074649A3 (en) | Methods of promoting scfa production by gut microbiota | |
| WO2024099364A3 (en) | Fused multicyclic compounds and their use as parp1 inhibitors | |
| WO2023122783A3 (en) | Tetrahydropyrazolopyrimidines and related analogs for inhibiting yap/taz-tead | |
| MX2021009539A (es) | Derivado del profarmaco 6-oxo-1,6-dihidropiridazina, metodo de preparacion del mismo y aplicacion del mismo en medicina. | |
| MX2025014320A (es) | Compuestos nitrogenados aromaticos, metodos de preparacion y usos medicinales | |
| JOP20200133A1 (ar) | طريقة لتحضير حمض (3s)-3-(4-كلورو-3-{[(2s،3r) -2-(4-كلورو فنيل) -4، 4، 4-ثلاثي فلورو-3-مثيل بيوتانويل] أمينو} فنيل) -3- بروبيل حلقي بروبانويك والشكل البلوري منه لاستخدامه كمركب فعال صيدلانياً | |
| WO2021242844A8 (en) | Grk2 inhibitors and uses thereof | |
| CN115551535A (zh) | 一种治疗脊髓性肌萎缩症的方法和药物 |